Tag: Therapy & Procedures: Misc.
Evidence Poor for Accuracy of Serological Tests for COVID-19
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
Convalescent Plasma Safe for Diverse Patients With COVID-19
Incidence of SAEs, including transfusion reactions, thromboembolic or thrombotic events, is low
Treatment Gap Remains in Stroke Care Between Men and Women
Size of this difference has narrowed compared with studies published before 2008
Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture
Human Trial of Antibody Therapy to Treat COVID-19 Underway
If drug proves safe and effective, it could be available for use by the fall
Convalescent Plasma Appears Promising for Severe COVID-19
In series of 25 patients, 19 experienced improvement in clinical status by day 14; 11 were discharged
Pulmonary Rehab Associated With Lower COPD Mortality
Only 1.5 percent of patients initiated pulmonary rehabilitation within 90 days of discharge
SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors
NT-proBNP Does Not Improve Evaluation of Syncope in the ED
Serum NT-proBNP concentrations were generally higher in patients with 30-day serious adverse events
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
